CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series D Preferred Stock | −5,150,751 | 0 | ||
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series D Preferred Stock | −998,553 | 0 | ||
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series D Preferred Stock | −507,724 | 0 | ||
| 2021-07-22 | Barnett Valerie General Counsel | Purchase | +1,900 | $17.00 | $32K | 1,900 |
| 2021-07-22 | Ball Jack Director | Purchase | +3,000 | $17.00 | $51K | 3,000 |
| 2021-07-22 | Dion Gisele Director | Purchase | +5,000 | $17.00 | $85K | 5,000 |
| 2021-07-22 | Poirson Allen SVP Marketing and Corp. Dev. | Purchase | +1,500 | $17.00 | $26K | 40,383 |
| 2021-07-22 | DENG FENG Director | Conversion | +147,933 | 147,933 | ||
| 2021-07-22 | DENG FENG Director | Conversion | +4,168,777 | 4,168,777 | ||
| 2021-07-22 | DENG FENG Director | Conversion | +443,800 | 443,800 | ||
| 2021-07-22 | DENG FENG Director | Conversion · Series A Preferred Stock | −147,933 | 0 | ||
| 2021-07-22 | DENG FENG Director | Conversion · Series C Preferred Stock | −4,168,777 | 0 | ||
| 2021-07-22 | DENG FENG Director | Conversion · Series D Preferred Stock | −443,800 | 0 | ||
| 2021-07-22 | Jiang Wenbin President and CEO | Conversion | +2,666,600 | 2,666,600 | ||
| 2021-07-22 | Jiang Wenbin President and CEO | Conversion · Series A Preferred Stock | −2,666,600 | 0 | ||
| 2021-07-22 | Yan Ming Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-07-22 | Barnett Valerie General Counsel | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-07-22 | Jeanmonod Patrik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-07-22 | Poirson Allen SVP Marketing and Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-07-22 | Jiang Wenbin President and CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 |
Page 49 of 49 · 980 trades